Meredith will be speaking on the panel, “Oversight Duties/Section 220,” which will offer guidance on best practices for exercising and documenting board oversight and discuss Caremark litigation after Marchand and developments in Section 220 litigation/Section 220 strategy after Amerisource Bergen.
Delaware law continues to play a critical role in U.S. corporate and securities law, particularly in today’s challenging and changing business environment. This unique program focuses on the important Delaware corporate law developments over the past year and how they impact corporate and legal practices. This expert faculty from the Delaware judiciary, leading law firms, corporations, and academia will examine the latest case law and practical trends, and will share their real-world experiences, insights and advice on the issues of greatest concern to the corporate/securities legal community.
This program is designed for outside counsel, corporate counsel, corporate directors, corporate committee members, investment bankers, consultants and other professionals with interest in the latest developments and important issues in Delaware corporate law.
What you will learn:
- Developments in oversight duties, and in Section 220 litigation and strategy
- Recent lessons from the pandemic and case law in structuring deals
- Fiduciary litigation
- Understanding the limits of corporate private ordering
- Ethical issues for transactional lawyers
